Form 4 Tracker
GeneDx Holdings Corp.
WGS

43 insider filings · Latest: Sep 17, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 26, 2025Mar 26 10:36 PMKevin Feeley
Proposed Sale
8,746$95.61$836.2K—

View →

Mar 26, 2025Mar 26 10:34 PMKatherine Stueland
Proposed Sale
46,551$95.62$4.5M—

View →

Mar 17, 2025Mar 17 10:46 PMKevin Feeley
Proposed Sale
3,749$96.72$362.6K—

View →

Mar 17, 2025Mar 17 10:44 PMKatherine Stueland
Proposed Sale
10,559$96.70$1.0M—

View →

Mar 13, 2025Mar 13 11:04 PMKevin Feeley
Proposed Sale
402$90.05$36.2K—

View →

Mar 13, 2025Mar 13 11:03 PMKatherine Stueland
Proposed Sale
1,078$89.42$96.4K—

View →

Mar 10, 2025Mar 10 11:44 PMKevin Feeley
Proposed Sale
922$94.69$87.3K—

View →

Mar 10, 2025Mar 10 11:43 PMKatherine Stueland
Proposed Sale
2,731$94.73$258.7K—

View →

Mar 3, 2025Mar 3 11:59 PMKevin Feeley
Proposed Sale
261$103.83$27.1K—

View →

Feb 24, 2025Feb 25 1:00 AMICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Proposed Sale
747,138$95.83$71.6M—

View →

Jan 30, 2025Jan 31 1:02 AMICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Proposed Sale
2,692,246$77.86$209.6M—

View →

Jan 29, 2025Jan 30 2:06 AMKevin Feeley
Proposed Sale
275$78.55$21.6K—

View →

Jan 29, 2025Jan 30 2:04 AMKatherine Stueland
Proposed Sale
1,657$78.46$130.0K—

View →

Jan 7, 2025Jan 7 10:02 PMFeeley Kevin
Proposed Sale
35,506$94.07$3.3M—

View →

Jan 7, 2025Jan 7 9:44 PMStueland Katherine
Proposed Sale
51,420$93.93$4.8M—

View →

Jan 2, 2025Jan 2 10:03 PMFeeley Kevin
Proposed Sale
1,430$75.52$108.0K—

View →

Jan 2, 2025Jan 2 9:31 PMStueland Katherine
Proposed Sale
18,006$77.75$1.4M—

View →

Dec 16, 2024Dec 17 1:41 AMKevin Feeley
Proposed Sale
3,728$76.75$286.1K—

View →

Dec 16, 2024Dec 17 1:40 AMKatherine Stueland
Proposed Sale
10,501$76.75$806.0K—

View →

Dec 9, 2024Dec 10 1:06 AMKevin Feeley
Proposed Sale
1,137$76.37$86.8K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 16, 2026Jun 18 8:09 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
18,750—56,250(D)

View →

Jun 9, 2026Jun 11 8:12 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
2,462—4,925(D)

View →

Jun 9, 2026Jun 11 8:11 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
6,546—13,094(D)

View →

Jun 1, 2026Jun 3 8:16 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
717—717(D)

View →

May 11, 2026May 12 12:43 AMCasdin Capital, LLCDirector, 10% Owner
Purchase
50,000—850,000(I)

View →

May 8, 2026May 12 12:43 AMCasdin Capital, LLCDirector, 10% Owner
Purchase
300,000—800,000(I)

View →

May 7, 2026May 12 12:43 AMCasdin Capital, LLCDirector, 10% Owner
Purchase
500,000—500,000(I)

View →

Apr 29, 2026May 1 8:28 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
3,874—0(D)

View →

Apr 29, 2026May 1 8:24 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
754—0(D)

View →

Mar 26, 2026Mar 30 9:38 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
16,250—32,500(D)

View →

Mar 26, 2026Mar 30 9:30 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
80,000—160,000(D)

View →

Mar 16, 2026Mar 17 10:40 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
18,750—75,000(D)

View →

Mar 15, 2026Mar 17 10:40 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
11,921—35,763(D)

View →

Mar 16, 2026Mar 17 10:39 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
7,197—28,787(D)

View →

Mar 15, 2026Mar 17 10:39 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
3,815—11,446(D)

View →

Mar 9, 2026Mar 11 8:28 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
2,462—7,387(D)

View →

Mar 9, 2026Mar 11 8:26 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
6,546—19,640(D)

View →

Mar 3, 2026Mar 5 10:50 PMBryan DechairoChief Operating Officer
Grant/Award
10,430—10,430(D)

View →

Mar 3, 2026Mar 5 10:49 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Grant/Award
10,865—10,865(D)

View →

Mar 3, 2026Mar 5 10:46 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Grant/Award
40,418—40,418(D)

View →